U
SZYM

UBS’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

UBS’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$4K Sell
500
-200
-29% -$1.87K ﹤0.01% 9712
2014
Q2 		$8K Sell
700
-3,500
-83% -$37.3K ﹤0.01% 9158
2014
Q1 		$49K Sell
4,200
-15,100
-78% -$178K ﹤0.01% 6868
2013
Q4 		$210K Buy
19,300
+9,800
+103% +$96.4K ﹤0.01% 5253
2013
Q3 		$102K Sell
9,500
-8,100
-46% -$92.3K ﹤0.01% 6002
2013
Q2 		$206K Buy
+17,600
New +$176K ﹤0.01% 5062

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T
Tahithromos New York $71.9M AUM 0.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

UBS's SZYM Position: Q3 2014 in Review

UBS reduced its SOLAZYME INC COM STK (DE) (SZYM) stake by 16% in Q3 2014, selling an estimated $175K and leaving 98,939 shares worth $738K. The position accounts for ﹤0.01% of the portfolio, ranked #3882.

UBS first reported a position in SZYM in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.39M in Q2 2014. 120 funds tracked by Wall St. Rank hold SZYM as of Q3 2014.

  • UBS held 98,939 shares of SOLAZYME INC COM STK (DE) worth $738K as of Q3 2014.
  • UBS sold 18,763 SOLAZYME INC COM STK (DE) shares in Q3 2014, an estimated $175K.
  • SOLAZYME INC COM STK (DE) made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3882 holding.
  • UBS first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and has held it in 6 quarters since.
  • UBS's SOLAZYME INC COM STK (DE) position peaked at $1.39M in Q2 2014.
  • 120 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.